Taiwan currently reports a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 534.66 million, a decrease of 36.25 million (-6.4%) from 2021.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Taiwan
No matching regions
Similar regions to Taiwan
Business R&D pharmaceutical in constant PPP $
Taiwan Business R&D pharmaceutical in constant PPP $ between 1999 and 2022
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2022 | 534.66M | -36.25M |
| 2021 | 570.91M | +24.63M |
| 2020 | 546.28M | +66.16M |
| 2019 | 480.12M | -21.33M |
| 2018 | 501.44M | -38.15M |
| 2017 | 539.59M | -2.06M |
| 2016 | 541.65M | +93.89M |
| 2015 | 447.76M | -37.69M |
| 2014 | 485.45M | +86.46M |
| 2013 | 398.99M | +39.06M |
| 2012 | 359.93M | +16.62M |
| 2011 | 343.30M | +63.57M |
| 2010 | 279.74M | +36.99M |
| 2009 | 242.75M | +18.26M |
| 2008 | 224.48M | +58.49M |
| 2007 | 166.00M | +14.84M |
| 2006 | 151.16M | +11.79M |
| 2005 | 139.36M | +12.16M |
| 2004 | 127.20M | +16.61M |
| 2003 | 110.60M | +1.71M |
| 2002 | 108.89M | +28.63M |
| 2001 | 80.26M | -15.95M |
| 2000 | 96.21M | +2.59M |
| 1999 | 93.62M |